Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 01, 2022

BUY
$20.4 - $25.53 $12,688 - $15,879
622 Added 4.7%
13,866 $309,000
Q1 2022

May 04, 2022

BUY
$24.7 - $36.54 $93,983 - $139,034
3,805 Added 40.31%
13,244 $285,000
Q4 2021

Feb 07, 2022

SELL
$35.83 - $45.03 $5,696 - $7,159
-159 Reduced 1.66%
9,439 $338,000
Q3 2021

Nov 02, 2021

SELL
$38.75 - $44.47 $45,841 - $52,608
-1,183 Reduced 10.97%
9,598 $408,000
Q2 2021

Aug 03, 2021

SELL
$39.42 - $48.08 $112,386 - $137,076
-2,851 Reduced 20.91%
10,781 $467,000
Q1 2021

May 04, 2021

SELL
$32.49 - $45.96 $7,342 - $10,386
-226 Reduced 1.63%
13,632 $556,000
Q4 2020

Feb 01, 2021

BUY
$32.59 - $45.26 $6,713 - $9,323
206 Added 1.51%
13,858 $627,000
Q3 2020

Nov 09, 2020

BUY
$32.56 - $38.57 $92,209 - $109,230
2,832 Added 26.17%
13,652 $483,000
Q2 2020

Aug 07, 2020

SELL
$27.83 - $37.73 $62,812 - $85,156
-2,257 Reduced 17.26%
10,820 $408,000
Q1 2020

May 04, 2020

BUY
$22.38 - $54.06 $51,742 - $124,986
2,312 Added 21.48%
13,077 $378,000
Q4 2019

Feb 06, 2020

SELL
$51.85 - $73.36 $11,562 - $16,359
-223 Reduced 2.03%
10,765 $558,000
Q4 2019

Feb 04, 2020

BUY
$51.85 - $73.36 $333,706 - $472,144
6,436 Added 141.39%
10,988 $452,000
Q3 2019

Nov 12, 2019

BUY
$40.05 - $57.47 $182,307 - $261,603
4,552 New
4,552 $250,000
Q3 2018

Nov 01, 2018

SELL
$32.83 - $42.51 $191,267 - $247,663
-5,826 Closed
0 $0
Q2 2018

Aug 02, 2018

BUY
$28.77 - $48.27 $22,958 - $38,519
798 Added 15.87%
5,826 $186,000
Q1 2018

May 04, 2018

BUY
$49.22 - $68.43 $49,662 - $69,045
1,009 Added 25.11%
5,028 $250,000
Q4 2017

Feb 01, 2018

BUY
$52.14 - $59.94 $18,144 - $20,859
348 Added 9.48%
4,019 $217,000
Q3 2017

Oct 27, 2017

SELL
$51.16 - $58.21 $19,901 - $22,643
-389 Reduced 9.58%
3,671 $213,000
Q2 2017

Aug 07, 2017

BUY
N/A
4,060
4,060 $200,000

Others Institutions Holding ANIK

About Anika Therapeutics, Inc.


  • Ticker ANIK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,599,900
  • Market Cap $358M
  • Description
  • Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...
More about ANIK
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.